Novel mutations in FKBP10 and PLOD2 cause rare bruck syndrome in Chinese Patients

Peiran Zhou*, Yi Liu, Fang Lv, Min Nie, Yan Jiang, Ou Wang, Weibo Xia, Xiaoping Xing, Mei Li

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Citations (Scopus)

Abstract

Bruck syndrome (BS) is an extremely rare form of osteogenesis imperfecta characterized by congenital joint contracture, multiple fractures and short stature. We described the phenotypes of BS in two Chinese patients for the first time. The novel compound heterozygous mutations c.764-772dupACGTCCTCC (p.255-257dupHisValLeu) in exon 5 and c.1405G.T (p.Gly469X) in exon 9 of FKBP10 were identified in one proband. The novel compound heterozygous mutations c.1624delT (p.Tyr542Thrfs∗18) in exon 14 and c.1880T<C (p.Val627Ala) in exon 17 of PLOD2 were identified in another probrand. Intravenous zoledronate was a potent agent for these patients, confirmed the efficacy of bisphosphonates on this disease. In conclusion, the novel causative mutations identified in the patients expand the genotypic spectrum of BS.

Original languageEnglish
Article numbere107594
JournalPLoS ONE
Volume9
Issue number9
DOIs
Publication statusPublished - 19 Sept 2014
Externally publishedYes

Fingerprint

Dive into the research topics of 'Novel mutations in FKBP10 and PLOD2 cause rare bruck syndrome in Chinese Patients'. Together they form a unique fingerprint.

Cite this